Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Haruna Matsuzaki"'
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0287122 (2023)
Among antipsychotics, clozapine is associated with a high risk of seizures. This study aimed to generate novel hypotheses regarding trends in the onset of clozapine-induced seizures using the JADER (Japanese Adverse Drug Event Report) database. Seizu
Externí odkaz:
https://doaj.org/article/f620578536804ea29505c2793b2eeec6
Publikováno v:
Neuropsychiatric Disease and Treatment.
Haruna Matsuzaki,1,* Masakazu Hatano,1,* Miko Iwata,1 Takeo Saito,2 Shigeki Yamada1 1Department of Clinical Pharmacy, Fujita Health University School of Medicine, Toyoake, 470-1192, Japan; 2Department of Psychiatry, Fujita Health University S
Autor:
Masakazu Hatano, Tomohiro Mizuno, Yuki Arakawa, Risa Inagaki, Arisa Kato, Haruna Matsuzaki, Fumihiro Mizokami, Takenao Koseki, Shigeki Yamada
Publikováno v:
Biologicalpharmaceutical bulletin. 45(8)
Polypharmacy in older adults causes problems such as increased adverse drug reactions, overdose or duplication, and poor medication adherence. We have established a "medication review team" organized by pharmacists. This prospective and retrospective
Publikováno v:
Neuropsychiatric Disease and Treatment
Haruna Matsuzaki,1 Masakazu Hatano,1,2 Miko Iwata,1 Shigeki Yamada1 1Department of Clinical Pharmacy, Fujita Health University School of Medicine, Toyoake, Aichi, Japan; 2Department of Psychiatry, Fujita Health University School of Medicine, Toyoake,
Autor:
Toshiyasu Makihara, Rika Kuki, Shigeki Yamada, Naoharu Mori, Kumiko Fukuura, Kimio Yasuda, Yuki Arakawa, Takahiro Hayashi, Haruna Matsuzaki, Akihiko Futamura, Hiroshi Takahashi, Saori Ikehata, Takashi Higashiguchi
Publikováno v:
Biologicalpharmaceutical bulletin. 37(12)
Morphine, oxycodone, and fentanyl are commonly used to control cancer pain. Because these drugs have differences in receptor affinity or pharmacokinetic parameters, changing the opioid formulation may result in an unexpected outcome, depending on the
Autor:
Masakazu Hatano, Hiroyuki Kamei, Risa Inagaki, Haruna Matsuzaki, Manako Hanya, Shigeki Yamada, Nakao Iwata
Publikováno v:
Clinical Psychopharmacology & Neuroscience; 2018, Vol. 16 Issue 2, p184-189, 6p